Single cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kvastad, L ^a   Werne Solnestam, B ^a   Johansson, E ^a   Nygren, A O ^b,c   Laddach, N ^b   Sahlen P ^a   Vickovic, S ^a   Bendigtsen, Schirmer C ^d   Aaserud, M ^d   Floer, L ^d   Borgen, E ^d   Schwind, C ^e   Himmelreich, R ^e   Latta, D ^e   Lundeberg, J ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b MRC HOLLAND   (Netherlands)

^c AGENA BIOSCIENCE   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e INSTITUT FÜR MIKROTECHNIK MAINZ GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASMS; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SINGLE CELL ANALYSIS; STANDARDS; TUMOR CELL LINE; TUMOR EMBOLISM;

CASE-CONTROL STUDIES; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, RNA; SINGLE-CELL ANALYSIS;

EID: 84983542835     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16519     Document Type: Article

References (32)

1. Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England journal of medicine 351, 781-791, doi: 10.1056/NEJMoa040766 (2004).
2. Ross, A. A. et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82, 2605-2610 (1993).
3. Stott, S. L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. USA 107, 18392-18397, doi: 10.1073/pnas.1012539107 (2010).
4. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239, doi: 10.1038/nature06385 (2007).
5. Saliba, A. E. et al. Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc. Natl. Acad. Sci. USA 107, 14524-14529, doi: 10.1073/pnas.1001515107 (2010).
6. Issadore, D. et al. Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci Transl Med 4, 141ra192, doi: 10.1126/scitranslmed.3003747 (2012).
7. Pecot, C. V. et al. A novel platform for detection of CK+ and CK-CTCs. Cancer Discov 1, 580-586, doi: 10.1158/2159-8290. CD-11-0215 (2011).
8. Zieglschmid, V. et al. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res. 25, 1803-1810 (2005).
9. Weigelt, B., and Bosma., A. J., Hart, A. A., Rodenhuis, S. & van 't Veer, L. J. Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients. Br. J. Cancer 88, 1091-1094, doi: 10.1038/sj.bjc.6600868 (2003).
10. Ramskold, D. et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 30, 777-782, doi: 10.1038/nbt.2282 (2012).
11. Yu, M. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510-513, doi: 10.1038/nature11217 (2012).
12. Raj, A. & van Oudenaarden, A. Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135, 216-226, doi: 10.1016/j.cell.2008.09.050 (2008).
13. Molloy, T. J., Bosma, A. J. & van't Veer, L. J. Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells. Breast Cancer Res. Treat. 112, 297-307, doi: 10.1007/s10549-007-9872-5 (2008).
14. Molloy, T. J. et al. A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer. Br. J. Cancer 104, 1913-1919, doi: 10.1038/bjc.2011.164 (2011).
15. Xi, L. et al. Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers. Clin. Chem. 53, 1206-1215, doi: 10.1373/clinchem.2006.081828 (2007).
16. Sieuwerts, A. M. et al. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res. Treat. 118, 455-468, doi: 10.1007/s10549-008-0290-0 (2009).
17. Obermayr, E. et al. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer 10, 666, doi: 10.1186/1471-2407-10-666 (2010).
18. Eldering, E. et al. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res. 31, e153 (2003).
19. Schouten, J. P. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).
20. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988, doi: 10.1073/pnas.0530291100 (2003).
21. Kristiansen, G. et al. CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res. 9, 4906-4913 (2003).
22. Nieman, M. T., and Prudoff., R. S., Johnson, K. R. & Wheelock, M. J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. The Journal of cell biology 147, 631-644 (1999).
23. Hazan, R. B., and Phillips., G. R., Qiao, R. F., Norton, L. & Aaronson, S. A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. The Journal of cell biology 148, 779-790 (2000).
24. Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584, doi: 10.1126/science.1228522 (2013).
25. Slamon, D. J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712 (1989).
26. Menard, S., Tagliabue, E., Campiglio, M. & Pupa, S. M. Role of HER2 gene overexpression in breast carcinoma. J. Cell. Physiol. 182, 150-162, doi: 10.1002/(SICI)1097-4652(200002)182:2 <150::AID-JCP3> 3.0.CO;2-E (2000).
27. Gilbey, A. M., Burnett, D., Coleman, R. E. & Holen, I. The detection of circulating breast cancer cells in blood. J. Clin. Pathol. 57, 903-911, doi: 10.1136/jcp.2003.013755 (2004).
28. Ring, A., Smith, I. E. & Dowsett, M. Circulating tumour cells in breast cancer. Lancet Oncol 5, 79-88, doi: 10.1016/S1470-2045(04)01381-6 (2004).
29. Yoon, S. Y. et al. Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. Biochem. Biophys. Res. Commun. 326, 7-17, doi: 10.1016/j.bbrc.2004.11.004 (2005).
30. Hardingham, J.E1., Kotasek, D., Farmer, B., Butler, R. N., Mi, J. X., Sage, R. E. & Dobrovic, A. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res. 53(15), 3455-8, Aug 1 (1993).
31. Vickovic, S., Ahmadian, A., Lewensohn, R. & Lundeberg, J. Toward Rare Blood Cell Preservation for RNA Sequencing. The Journal of molecular diagnostics: JMD 17, 352-359, doi: 10.1016/j.jmoldx.2015.03.009 (2015).
32. Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897-6904, doi: 10.1158/1078-0432.CCR-04-0378 (2004).